Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Dade Behring Holdings

With 2005 revenue of nearly $1.7 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of clinical laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients. The businesses from which Dade Behring was formed have been innovators in clinical diagnostics for more than a century. Dade Behring was created in 1997 through the merger of Dade International and the Behring Diagnostics unit of Hoechst AG. Earlier, these companies had combined the diagnostics businesses of the DuPont Company, Syva Company and Baxter Healthcare. Now, Dade Behring ranks as the sixth largest diagnostics company in the world. The company has four core product lines: Chemistry/Immunochemistry, Hemostasis, Microbiology and Infectious Disease Diagnostics. Dade Behring's chemistry/immunochemistry business consists of: Routine Chemistry/Immunochemistry, Cardiac, Plasma Proteins and Drugs-of-Abuse Testing/Therapeutic Drug Monitoring. These products are used to detect and measure substances that may be found in patients' blood, urine or tissue samples. Key products include the following: Routine chemistry/ immunochemistry testing: The Dimension® family of products remain the only systems in the marketplace that integrate highly sensitive immunochemistry testing into the same instrument as routine chemistry testing. This unique product capability can eliminate the need for multiple instruments, simplifying workflow, reducing overall costs, and increasing efficiency in the clinical laboratory. Dade Behring also offers workcells that automate labor-intensive activities by connecting up to six Dimension® analyzers. Cardiac testing: In addition to its broad cardiac test menu on the Dimension® systems, Dade Behring also offers a highly advanced, automated bench-top analyzer called the Stratus® CS Acute Care Diagnostic System. The company is an industry leader in introducing highly-sensitive cardiac marker tests, including Troponin I, high-sensitivity c-reactive protein (hsCRP), and the NT-proBNP tests. Plasma Protein testing: Dade Behring's plasma protein tests diagnose a range of disease and disorders, from heart disease, rheumatic disease, tumors, malnutrition and more through the testing of serum, plasma, urine or cerebral/spinal fluid. Drugs-of-abuse testing (DAT) and therapeutic drug monitoring (TDM): Drugs-of-abuse tests screen for the presence of illicit drugs in a patient's system, while monitoring of therapeutic drugs enable physicians to ensure that therapeutic drugs are present in safe levels in the bloodstream. The Syva® brand remains, after three decades, the leading brand in the drugs-of-abuse and therapeutic drug monitoring market. Dade Behring was a pioneer in the field of Hemostasis (coagulation), and it continues to maintain a global leadership position in this product line. Many of its hemostasis tests measure patients' ability to form and dissolve blood clots, and are generally used before and during surgical procedures or for monitoring coagulation disorders such as hemophilia. Microbiology laboratories use Dade Behring's highly specific MicroScan® products to identify infection-causing bacteria and the minimum dose of antibiotics necessary to treat the infection - critical data in managing patient therapy and health care resources. Dade Behring has taken a leadership role in detecting emerging antimicrobial resistance, and is the only company offering an automated system cleared for improved detection of vancomycin-resistant Staphylococcus aureus (VRSA). Outside of the U.S. market, Dade Behring's (IDD) systems are primarily used for virology testing, including screening for infections such as hepatitis, HIV and sexually transmitted diseases. Dade Behring is headquartered in Deerfield, Illinois, and has operations in 34 countries, employs approximately 6,300 people and serves more than 25,000 customers worldwide.


Contact Details:
1717 Deerfield Road
Deerfield
Illinois
60015-0778
United States of America
Tel:1 (847) 267-5300
Fax:
Email:
WWW:

www.dadebehring.com




Loading...

Press Releases on Dade Behring Holdings:

BioPortfolio Logo
Reportlinker Adds Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Global In Vitro Diagnostics Investment Opportunities, Analysis and

Dade Behring Holdings (DADE) Financial information Links from Barchart

DADE Quote from from Barchart.com
DADE Chart from from Barchart.com
DADE Profile from from Barchart.com
DADE Opinion from from Barchart.com

View more Dade Behring Holdings finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 628 times since April 2007, the link to the organisation's website has been followed 101 times

Recent Search Terms used to find this page: Dade Behring email | Dimension exl dade | dade behring dupont | dade behring diagnostics pdf | protein S dade behring | chemistry immunochemistry work flow | dade behring chemistry us | dade behring therapeutic drug | DADE behring | DADE behring | .

Search for more companies in Deerfield

Search for more companies in Illinois



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Dade Behring Holdings

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.